Recent Advances in the Research of HIV-1 RNase H Inhibitors
Article 2008 en
Authors
FY
Fang Yu
XL
Xinyong Liu
PZ
Peng Zhan
Abstract
1 min read
Reverse transcription is a crucial step in the life cycle of human immunodeficiency virus type 1 (HIV-1). In this process, multiple functional enzymes including RNA-dependent DNA polymerase, DNA-dependent DNA polymerase and RNase H are indispensable. The RNase H functions to degrade RNA of the RNA-DNA heteroduplex into small fragment. These properties of HIV-1 RNase H make it an attractive target for rational anti-HIV-1 drug design and development. In this review, we summarized the HIV-1 RNase H inhibitors that were recently reported in the literature, including their chemical structure, mechanism and structure-activity relationship. It seems likely that HIV-1 RNase H as a prominent non-traditional target may lead to the development of anti-HIV agents which could be used alone or in the combination with other HIV inhibitors in AIDS chemotherapy.
Yiying Zhang, Robert Wang, Yang Bu, Angela Corona, Laura Dettori, Enzo Tramontano, Christophe Pannecouque, De Clercq Erik, Shuai Wang, Ge Meng, Fen‐Er Chen
Discussion(0)
No comments yet. Be the first to comment.